BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,304,179 | +221.3% | 128,675 | +310.5% | 0.01% | +200.0% |
Q1 2024 | $1,339,600 | -36.5% | 31,343 | -42.5% | 0.00% | -40.0% |
Q4 2023 | $2,108,015 | +1.6% | 54,527 | -0.8% | 0.01% | -16.7% |
Q3 2023 | $2,074,229 | -6.5% | 54,961 | +12.8% | 0.01% | 0.0% |
Q2 2023 | $2,219,409 | -5.3% | 48,714 | -15.7% | 0.01% | 0.0% |
Q1 2023 | $2,343,070 | -0.3% | 57,768 | +25.3% | 0.01% | -14.3% |
Q4 2022 | $2,350,840 | +24.1% | 46,122 | +31.1% | 0.01% | +16.7% |
Q3 2022 | $1,895,000 | -77.7% | 35,173 | -73.4% | 0.01% | -76.9% |
Q2 2022 | $8,481,000 | -72.9% | 132,032 | -67.3% | 0.03% | -64.9% |
Q1 2022 | $31,273,000 | -40.7% | 403,262 | -34.3% | 0.07% | -33.9% |
Q4 2021 | $52,708,000 | +0.4% | 614,035 | -5.9% | 0.11% | -3.4% |
Q3 2021 | $52,488,000 | -26.3% | 652,571 | -26.3% | 0.12% | -26.6% |
Q2 2021 | $71,255,000 | +42.5% | 885,159 | +49.4% | 0.16% | +28.5% |
Q1 2021 | $49,987,000 | -26.0% | 592,665 | -29.6% | 0.12% | -30.9% |
Q4 2020 | $67,556,000 | -19.3% | 841,922 | -19.1% | 0.18% | -31.3% |
Q3 2020 | $83,719,000 | -12.3% | 1,041,039 | -6.1% | 0.26% | -20.1% |
Q2 2020 | $95,456,000 | +2.6% | 1,108,644 | -3.3% | 0.32% | -13.1% |
Q1 2020 | $93,078,000 | -9.1% | 1,146,415 | -6.4% | 0.37% | +13.7% |
Q4 2019 | $102,370,000 | -37.2% | 1,224,193 | -34.3% | 0.33% | -43.0% |
Q3 2019 | $162,962,000 | +5.7% | 1,863,075 | -1.1% | 0.58% | +5.5% |
Q2 2019 | $154,233,000 | -2.3% | 1,883,167 | -3.0% | 0.54% | -6.2% |
Q1 2019 | $157,903,000 | +10.2% | 1,941,997 | -10.8% | 0.58% | -9.6% |
Q4 2018 | $143,265,000 | -18.6% | 2,177,375 | -4.6% | 0.64% | -7.7% |
Q3 2018 | $176,038,000 | +2.7% | 2,283,099 | -1.6% | 0.70% | -10.8% |
Q2 2018 | $171,390,000 | +7.7% | 2,320,695 | -5.1% | 0.78% | +4.6% |
Q1 2018 | $159,109,000 | -2.6% | 2,445,831 | -3.2% | 0.75% | -11.7% |
Q4 2017 | $163,305,000 | +9.2% | 2,525,870 | +6.0% | 0.85% | -8.9% |
Q3 2017 | $149,571,000 | +2.6% | 2,383,661 | -1.0% | 0.93% | -1.1% |
Q2 2017 | $145,767,000 | +17.5% | 2,407,777 | +0.6% | 0.94% | +13.7% |
Q1 2017 | $124,095,000 | +29.3% | 2,392,882 | +10.5% | 0.83% | +10.0% |
Q4 2016 | $95,984,000 | +9.6% | 2,164,668 | +17.6% | 0.75% | +16.1% |
Q3 2016 | $87,593,000 | +260.5% | 1,840,147 | +242.4% | 0.65% | +251.6% |
Q2 2016 | $24,300,000 | +144.8% | 537,362 | +122.4% | 0.18% | +130.0% |
Q1 2016 | $9,926,000 | +191.9% | 241,657 | +171.2% | 0.08% | +175.9% |
Q4 2015 | $3,400,000 | +389.2% | 89,100 | +321.2% | 0.03% | +480.0% |
Q3 2015 | $695,000 | -53.0% | 21,153 | 0.0% | 0.01% | -54.5% |
Q2 2015 | $1,480,000 | -76.8% | 21,153 | -77.3% | 0.01% | -77.1% |
Q1 2015 | $6,381,000 | -15.5% | 93,184 | -9.6% | 0.05% | -11.1% |
Q4 2014 | $7,553,000 | +5.2% | 103,043 | +3.0% | 0.05% | +5.9% |
Q3 2014 | $7,181,000 | -1.7% | 100,045 | -0.9% | 0.05% | -1.9% |
Q2 2014 | $7,302,000 | +5.9% | 100,998 | +7.8% | 0.05% | -1.9% |
Q1 2014 | $6,895,000 | +7.0% | 93,703 | +1.1% | 0.05% | -1.9% |
Q4 2013 | $6,445,000 | +2.3% | 92,683 | -3.3% | 0.05% | -11.5% |
Q3 2013 | $6,298,000 | -11.4% | 95,872 | -6.6% | 0.06% | -15.3% |
Q2 2013 | $7,111,000 | – | 102,673 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |